WVE

4.67

2.91% -0.14

Dopo l'orario di chiusura: 4.68 0.010 +0.21%

Wave Life Sciences Ltd (WVE)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WVE Giù? Forum Previsione

Precedente Chiudi:

$4.81

Aprire:

$4.76

Volume 24 ore:

2.77M

Relative Volume:

0.89

Capitalizzazione di mercato:

$920.21M

Reddito:

$71.80M

Utile/perdita netta:

$-183.59M

Rapporto P/E:

-4.4295

EPS:

-1.0543

Flusso di cassa netto:

$-186.52M

1 W Prestazione:

-0.64%

1M Prestazione:

-23.06%

6M Prestazione:

-66.04%

1 anno Prestazione:

-36.81%

Intervallo 1D:

$4.63

$4.76

Intervallo di 1 settimana:

$4.63

$4.965

Portata 52W:

$4.63

$21.73

Wave Life Sciences Ltd Stock (WVE) Company Profile

Nome

Wave Life Sciences Ltd

Settore

Healthcare (1069)

Industria

Biotechnology (595)

Telefono

617-949-2900

Indirizzo

7 STRAITS VIEW, SINGAPORE

Dipendente

317

Cinguettio

@WAVELifeSci

Prossima data di guadagno

2026-07-30

Ultimi documenti SEC

WVE's Discussions on Twitter

Compare WVE vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WVE Wave Life Sciences Ltd	4.67	947.80M	71.80M	-183.59M	-186.52M	-1.0543
VRTX Vertex Pharmaceuticals Inc	514.56	132.08B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	793.26	83.15B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	984.04	62.71B	4.16B	1.29B	734.26M	19.58
MRNA Moderna Inc	136.62	54.14B	2.23B	-3.19B	-1.60B	-8.1462
RVMD Revolution Medicines Inc	203.35	44.51B	742.00K	-1.37B	-1.07B	-7.0731

Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-04-29	Ripresa	Truist	Buy
2026-02-05	Iniziato	BofA Securities	Buy
2025-12-12	Reiterato	Wedbush	Outperform
2025-12-09	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2025-10-20	Iniziato	Wells Fargo	Overweight
2025-08-04	Iniziato	Canaccord Genuity	Buy
2025-07-28	Iniziato	Oppenheimer	Outperform
2025-07-16	Iniziato	Citigroup	Buy
2025-06-11	Ripresa	Raymond James	Outperform
2025-04-29	Iniziato	Cantor Fitzgerald	Overweight
2025-04-08	Iniziato	Wedbush	Outperform
2025-02-25	Iniziato	Jefferies	Buy
2024-10-16	Aggiornamento	Raymond James	Outperform → Strong Buy
2024-09-27	Ripresa	JP Morgan	Overweight
2024-09-19	Iniziato	B. Riley Securities	Buy
2024-09-09	Iniziato	JP Morgan	Overweight
2024-05-15	Iniziato	Wells Fargo	Overweight
2023-12-19	Aggiornamento	Leerink Partners	Market Perform → Outperform
2023-07-05	Iniziato	Raymond James	Outperform
2023-05-24	Downgrade	Jefferies	Buy → Hold
2020-12-15	Ripresa	H.C. Wainwright	Buy
2020-10-23	Iniziato	RBC Capital Mkts	Sector Perform
2019-12-31	Downgrade	SVB Leerink	Outperform → Mkt Perform
2019-11-01	Iniziato	Guggenheim	Buy
2019-07-15	Iniziato	Cowen	Market Perform
2019-04-17	Reiterato	H.C. Wainwright	Buy
2018-08-07	Iniziato	Stifel	Buy
2018-07-23	Iniziato	H.C. Wainwright	Buy
2018-03-19	Reiterato	Mizuho	Buy
2017-02-15	Iniziato	H.C. Wainwright	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-12-07	Iniziato	JMP Securities	Mkt Outperform
2015-12-07	Iniziato	Jefferies	Buy
2015-12-07	Iniziato	Leerink Partners	Outperform
2015-12-07	Iniziato	Sun Trust Rbsn Humphrey	Buy

Mostra tutto

Wave Life Sciences Ltd Borsa (WVE) Ultime notizie

Sep 10, 2026

Wave Life Sciences at Cantor conference: RNA editing gains traction By Investing.com - Investing.com Canada

Sep 10, 2026

Sep 04, 2026

Wave Life Sciences stock holds steady ahead of Cantor healthcare conference appearance - ad-hoc-news.de

Sep 04, 2026

Sep 03, 2026

Wave Life Sciences to Present at Cantor 2026 Global Healthcare Conference - Yahoo Finance

Sep 03, 2026

Sep 02, 2026

Wells Fargo Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $14 - Moomoo

Sep 02, 2026

Aug 31, 2026

Wave Life Sciences stock trades quietly as investors focus on recent clinical progress - ad-hoc-news.de

Aug 31, 2026

Aug 21, 2026

WAVE Life Sciences (NASDAQ:WVE) Downgraded by Zacks Research to "Hold" - MarketBeat

Aug 21, 2026

Wave Life Sciences (WVE) Files To Deregister Its Ordinary Shares - simplywall.st

Aug 21, 2026

What Went Wrong For WVE? The Obesity Drug Trial Data That Spooked Investors - Stocktwits

Aug 21, 2026

Aug 20, 2026

WVE Stock Edges Up After Positive Early Data For Rare Disease Drug - Stocktwits

Aug 20, 2026

Aug 19, 2026

Wave Life Sciences targets fat loss without sacrificing muscle - Longevity.Technology

Aug 19, 2026

Aug 18, 2026

Insiders Sold Wave Life Sciences Prematurely At US$13.64 With Stock Trading Higher - Moomoo

Aug 18, 2026

Aug 17, 2026

Wave Life Sciences (WVE) Pulls Back 5.2% to $5.13 as Support Holds at $4.87Thematic ETF Flow - vinanet.vn

Aug 17, 2026

Wave Life Sciences Ltd. SEC Filing (Aug 17, 2026) - Stock Titan

Aug 17, 2026

Aug 15, 2026

Precision Trading with Wave Life Sciences Ltd. (WVE) Risk Zones - Stock Traders Daily

Aug 15, 2026

Aug 14, 2026

Wave Life Sciences, Inc.: Top Mutual Funds Holders | WVE | US94352A1043 - marketscreener.com

Aug 14, 2026

Wave Life Sciences, Inc.: Target Price Consensus and Analysts Recommendations | WVE | US94352A1043 - marketscreener.com

Aug 14, 2026

Wave Life Sciences, Inc.: Performance & Quotes, WVE Stock Price on Nasdaq Exchange - marketscreener.com

Aug 14, 2026

Wave Life Sciences, Inc.: Fundamental Analysis and Financial Ratings | WVE | US94352A1043 - marketscreener.com

Aug 14, 2026

Wave Life Sciences, Inc.: Financial Data Forecasts Estimates and Expectations | WVE | US94352A1043 - marketscreener.com

Aug 14, 2026

Wave Life Sciences, Inc. Stock (WVE)Quote Nasdaq - marketscreener.com

Aug 14, 2026

Q1 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus

Aug 14, 2026

WAVE Life Sciences Ltd at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus

Aug 14, 2026

Q2 2026 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus

Aug 14, 2026

Wave Life Sciences Ltd.: Revenue and Earnings Analysts Forecasts Revisions | WVE | US94352A1043 - marketscreener.com

Aug 14, 2026

Wave Life Sciences (WVE) Director Adrian Rawcliffe Sells 12,700 Shares, Reducing Stake to Zero - GuruFocus

Aug 14, 2026

Aug 13, 2026

WAVE Life Sciences (NASDAQ:WVE) Director Adrian Rawcliffe Sells 12,700 Shares - MarketBeat

Aug 13, 2026

Ken Takanashi Sells 3,864 Shares of WAVE Life Sciences (NASDAQ:WVE) Stock - MarketBeat

Aug 13, 2026

Wave Life Sciences (WVE) director’s 3,864-share tax sale under 10b5-1 plan - Stock Titan

Aug 13, 2026

Wave Life Sciences: A $1 Billion RNA-Medicine Bargain Ripe for Pharma Takeover - Yahoo Finance

Aug 13, 2026

Aug 12, 2026

Wave Life Sciences (WVE) Stock Looks Cheap After A 68% Fall But Expensive On Sales - simplywall.st

Aug 12, 2026

Wave Life Sciences Ltd. SEC Filing (Aug 12, 2026) - Stock Titan

Aug 12, 2026

Wave Life Sciences at canaccord growth conference: obesity and RNA bets - Investing.com Canada

Aug 12, 2026

BofA Securities Maintains Wave Life Sciences(WVE.US) With Buy Rating, Maintains Target Price $17 - Moomoo

Aug 12, 2026

WAVE Life Sciences (NASDAQ:WVE) Hits New 52-Week LowHere's What Happened - MarketBeat

Aug 12, 2026

Wave Life Sciences: An Fairly Valued RNA Opportunity - Seeking Alpha

Aug 12, 2026

Aug 11, 2026

Wave Life Sciences stock hits 52-week low at $5.01 By Investing.com - Investing.com Australia

Aug 11, 2026

RA Capital group discloses 16.8% Wave Life Sciences (WVE) ownership after redomiciliation - Stock Titan

Aug 11, 2026

Wave Life Sciences Ltd. SEC Filing (Aug 11, 2026) - Stock Titan

Aug 11, 2026

Wave Life Sciences stock hits 52-week low at $5.01 - Investing.com

Aug 11, 2026

Wave Life Sciences at Bank of America SMID Cap Virtual Conference: pipeline bets - Investing.com Nigeria

Aug 11, 2026

WAVE Life Sciences (NASDAQ:WVE) Stock Price Down 6.8%Should You Sell? - MarketBeat

Aug 11, 2026

Q2 2025 WAVE Life Sciences Ltd Earnings Call Transcript - GuruFocus

Aug 11, 2026

Wave Life Sciences Inc (FRA:0VS) Stock Earnings Transcripts - GuruFocus

Aug 11, 2026